Future HIV vaccine acceptability among young adults in South Africa.
about
Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approachesContextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials.Relationship-level analysis of drug users' anticipated changes in risk behavior following HIV vaccinationHIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study.A Kenyan newspaper analysis of the limitations of voluntary medical male circumcision and the importance of sustained condom use.Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: a social network analysisAcceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations.Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence.Conceptual framework for behavioral and social science in HIV vaccine clinical research.Willingness to participate in trials and to be vaccinated with new tuberculosis vaccines in HIV-infected adultsPerceptions of sexual risk compensation following posttrial HIV vaccine uptake among young South Africans.Inclusion of South African adolescents in HIV vaccine trials.Acceptability of vaccination against HIV: A mapping of Togolese people's positions.'The study has taught me to be supportive of her': empowering women and involving men in microbicide research.Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
P2860
Q27005602-AF624929-70FE-46A4-A38C-4FB1E4349156Q30148638-122E0F2F-204D-422E-B630-DE5ABFD93941Q30204590-8EBCA818-E875-474C-8C5B-B5CA87917D6EQ33786360-EAD6D380-7C61-45EC-B748-E0C3DE8A80D5Q34312642-7E794940-DC93-4903-90BD-CFD5BFFE7F68Q34786117-D7A81B13-E9E5-4639-84C6-8AA80F368A5FQ34989216-35AA2ECD-4D29-4B05-A971-8BD50BFC9833Q35121855-CE17439A-33F5-4F2C-BBE7-715194D2888FQ35301155-8F49416F-9BAD-4F75-B254-AB7FA6DB1C5BQ35719108-AD7291DA-D95D-49D0-8D46-580C268DB8A5Q37075094-FCC4F484-6626-4C1A-B901-059D9B69610CQ37698508-A25DFE1A-8CB0-49CD-94AF-909C9A0AAE14Q38822912-D0F041D1-DDFA-4CA0-A288-BD39D29FD317Q38868992-29CDA97C-310E-4BB4-B925-BA05EBD46309Q50114646-C977DCC3-8E7A-44FF-A3FA-5D36027018FD
P2860
Future HIV vaccine acceptability among young adults in South Africa.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Future HIV vaccine acceptability among young adults in South Africa.
@ast
Future HIV vaccine acceptability among young adults in South Africa.
@en
type
label
Future HIV vaccine acceptability among young adults in South Africa.
@ast
Future HIV vaccine acceptability among young adults in South Africa.
@en
prefLabel
Future HIV vaccine acceptability among young adults in South Africa.
@ast
Future HIV vaccine acceptability among young adults in South Africa.
@en
P2860
P356
P1476
Future HIV vaccine acceptability among young adults in South Africa.
@en
P2093
Jennifer N Sayles
William E Cunningham
P2860
P304
P356
10.1177/1090198109335654
P577
2009-06-09T00:00:00Z